LUND, Sweden, Feb. 15, 2018 /PRNewswire/ — NeuroVive Pharmaceutical AB(publ)(Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces that the Board of Directors of NeuroVive Pharmaceutical AB (publ) (“NeuroVive” or “the Company”) on 15 February 2018 resolved, subject to approval by the…